Ganitumab Biosimilar - Anti-IGF1 Receptor Antibody - Low endotoxin, Azide free (A323468)

Recombinant human monoclonal antibody to IGF1 Receptor for ELISA, FACS, Functional Assay and In Vivo.

Freight Charges
Lead Time
7-10 Business Days
Telephone
+1 (314) 370-6046
Mon - Fri, 8am - 4pm AST
Email
orders@antibodies.com
Name
Ganitumab Biosimilar - Anti-IGF1 Receptor Antibody - Low endotoxin, Azide free
Description
Recombinant human monoclonal antibody to IGF1 Receptor.
Applications
ELISA, FACS, Functional Assay, In Vivo
Reactivity
Human
Host
Human
Clonality
Monoclonal
Isotype
IgG1
Light Chains
kappa
Conjugate

Unconjugated

Purification
Protein A affinity chromatography.
Concentration
Reconstitution dependent.
Molecular Weight
This antibody has a predicted MW of 145.7 kDa.
Purity
> 95% (by SDS-PAGE).
Product Form
Lyophilized
Reconstitution
Reconstitute with 100µl of sterile double-distilled water to bring antibody to 1mg/ml concentration. Gently shake to solubilize completely. Do not vortex!
Formulation
Lyophilized from 25mM Histadine, pH 6.2, with 8% Sucrose and 0.01% Tween80.
Storage
Shipped at 4°C. Lyophilized: Store at -20°C to -80°C. Reconstituted: Aliquot and store at -80°C. Product is stable for one year. Avoid freeze/thaw cycles.
Synonyms
CD221, CD221 antigen, IGF 1 receptor, IGF 1R, IGF I receptor, IGF-I receptor, Igf1r, IGF1R_HUMAN, IGFIR, IGFIRC, IGFR, Insulin like growth factor 1 receptor, Insulin like growth factor 1 receptor precursor, Insulin-like growth factor 1 receptor beta chain, Insulin-like growth factor I receptor, JTK13, MGC142170, MGC142172, MGC18216, Soluble IGF1R variant 1, Soluble IGF1R variant 2
Disclaimer
This product is for research use only. It is not intended for diagnostic or therapeutic use.
Publishing research using Ganitumab Biosimilar - Anti-IGF1 Receptor Antibody - Low endotoxin, Azide free (A323468)? Please let us know so that we can list the citation on this page.

Alternative products to Ganitumab Biosimilar - Anti-IGF1 Receptor Antibody - Low endotoxin, Azide free (A323468)

Top